accacc2022acc2023acc2024acuteaddressingadherenceadjuvantadultsadvancedanalysisapproachesartarterialasco2021ashash2021ash2023ash2024asthmaatrialbasedbccbenefitbenefitsbetabetterbloodbreakingbreastcancercarcinomacardiologycardiovascularcarecellcervicalchallengeschemotherapychest2024cholesterolchronicclinicalcllcombinationcontrolcopdcoronarycovidcurrentcvdatadiabetesdiagnosisdiffusediseasediseasesearlyeaseas2022easd2022effectefficacyehaeha2025ehra2022ers2024escesc2021esc2022esc2023esc2024eshesh2022esh2023esh2024esh2025esmoesmo2021esmo2023esmo2024eular2024eventsevidencefailurefibrillationfirstfocusfuturegallenglpguidanceguidelineshearthelpher2hfpefhighhighlightshrhypertensionhypertensiveimmunotherapyimproveimprovesinhibitorinhibitorsinsightsinterviewish2021isth2022jointjourneykeynotekidneylandscapelargelateleukemialifeliraglutidelongloweringlunglymphocyticlymphomamanagementmanagingmelanomametastaticmultiplemyeloidmyelomanovelnoveltiesobesityoptimaloptionsoutcomesoverallpacingpatientpatientspembrolizumabpeoplephasepluspositivepostpracticepressurepreventionprogressionprostatepulmonaryquestionsrandomizedrccrealreceptorrecurrencerefractoryrelapsedrenalresultsriskrolesabcs2021sabcs2024secondarysemaglutidesessionsglt2showsststandardstatestrategiesstudysurgerysurvivalsymposiumsyndromestargettargetedtermtherapeutictherapiestherapytimetreatmenttrialtrialstripleupdateupdatesvaccineversusworldwvcdc